AGEN Earnings

AGEN reported its FY2025Q3 earnings on 2025-11-10, showcasing a revenue of 30.00M against an estimate of 80.00M, resulting in a -62.43% surprise. The EPS was 1.94, surpassing the expected 2.31 by -16.02% . The stock experienced a 5.78% price change on the earnings day and a 8.79% change over the next five days, reflecting market reactions to the results.

Following AGEN's FY2025Q3 earnings announcement on 2025-11-10, the stock price moved by 5.78% on the day of the release. Over the subsequent five days, it saw a 8.79% change. Historically, AGEN's stock price tends to shift by an average of +8.01% in the 10 days leading up to earnings and -5.26% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate AGEN’s annual revenue to reach 53.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 25.47% and EPS estimates Revise Downward by -6.95% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between AGEN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 25.47%, while EPS estimates moved Revise Downward by -6.95% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, AGEN's stock price typically moves by +8.01% in the 10 days before its earnings and -5.26% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 53.00M.

The earnings call reveals significant financial and operational challenges, such as a drastic cash balance decline and high net loss, despite improved operational efficiency. The Q&A indicates some uncertainty in regulatory processes and management's evasive responses to critical questions. Positive aspects, like potential equity investment and licensing agreements, are overshadowed by financial instability and competitive pressures. The lack of clear guidance and liquidity concerns suggest a negative market reaction, especially without a disclosed market cap to assess stock volatility.